Earth Science TechETST +6.67%37 Days Payable is 25.06 as of Mar. 2026, which is 80% below its 10-year median of 123.63. GuruFocus rates ETST with a GF Score™ of 37/100 and a GF Value™ of $0.23 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 920 Drug Manufacturers companies, Earth Science Tech ranks worse than 89.24% on this metric.
The historical rank and industry rank for Earth Science Tech's Days Payable or its related term are showing as below:
ETST'
s Days Payable Range Over the Past 10 Years
Min: 20.99 Med: 123.63 Max: 4859.91
Current: 30.54
During the past 13 years, Earth Science Tech's highest Days Payable was 4859.91. The lowest was 20.99. And the median was 123.63.
ETST's Days Payable is ranked worse than 89.24% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs ETST: 30.54
Earth Science Tech's Days Payable
increased
from Mar. 2025 (11.46) to Mar. 2026 (25.06).
It may suggest that Earth Science Techdelayed paying its suppliers.
Earth Science Tech Days Payable Related Terms
Earth Science Tech Days Payable Historical Data
* Premium members only.
The historical data trend for Earth Science Tech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Earth Science Tech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Earth Science Tech Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Earth Science Tech's Days Payable distribution charts can be found below:
* The bar in red indicates where Earth Science Tech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Earth Science Tech's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earth Science Tech (ETST) has a Days Payable of 25.06 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Earth Science Tech and its competitors. This is 80% below median its historical median of 123.63. Over the past decade, Earth Science Tech's Days Payable has ranged from 20.99 to 4,859.91. According to the industry distribution chart, Earth Science Tech ranks #821 out of 920 companies in the Drug Manufacturers industry, placing it in the top 89.2%.
Is Earth Science Tech's Days Payable too high?
Earth Science Tech's current Days Payable of 25.06 is 80% below median its 10-year median of 123.63. Over the past 10 years, this metric has ranged from a low of 20.99 to a high of 4,859.91. The Drug Manufacturers industry median Days Payable is 90.84. Earth Science Tech's value of 25.06 is 72.4% below this industry median. Based on the distribution chart, Earth Science Tech ranks #821 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Earth Science Tech has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Earth Science Tech's Days Payable compare to SCYX and INIS?
According to the Drug Manufacturers industry distribution chart, Earth Science Tech ranks #821 out of 920 companies for Days Payable. This places Earth Science Tech in the lower half of its industry. The industry median Days Payable is 90.84. Earth Science Tech's value of 25.06 is 72.4% below this benchmark. Historically, Earth Science Tech's own Days Payable has ranged from 20.99 to 4,859.91 over the past decade. While the company's 10-year median is 123.63 vs. the industry median of 90.84, Earth Science Tech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Earth Science Tech's current Days Payable of 25.06 is 72.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Earth Science Tech and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earth Science Tech's current Days Payable is 25.06, which is 80% below median its own 10-year median of 123.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earth Science Tech stock overvalued right now?
Based on GuruFocus' analysis, Earth Science Tech (ETST) is currently considered Possible Value Trap. The stock's GF Value™ is $0.23, compared to a current price of $0.16 — trading 30.4% below its estimated fair value. The current Days Payable is 25.06, which is 80% below median its 10-year median of 123.63 and 72.4% below the Drug Manufacturers industry median of 90.84. Earth Science Tech's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Earth Science Tech (ETST), the current Days Payable is 25.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Earth Science Tech (ETST) Overvalued in 2026?
Based on GuruFocus' analysis, Earth Science Tech stock appears to be undervalued.
The current stock price of $0.16 is trading 30.4% below its estimated GF Value™ of $0.23.
GuruFocus considers Earth Science Tech to be Possible Value Trap.
Key valuation signals for ETST:
Days Payable: 25.06 (80% below median its 10-year median of 123.63)
GF Value™: $0.23 vs. price of $0.16 (30.4% below fair value)
Industry Position: 72.4% below the Drug Manufacturers median (#821 of 920)
No single metric tells the full story. See the ETST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Earth Science Tech Inc is a diversified holding company. The company focuses on the health and wellness sector. The Company's principal operating plan is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The Company's healthcare operations are supported by investments in real estate and asset management activities and a consumer products business. The core of the Company's value proposition is the seamless integration of patient care, from consultation to fulfillment.
37GF Score
Get the complete analysis for ETST
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ETST has been successfully added to your 
